ResearchEarly experience with proton craniospinal irradiation in adult patients with leptomeningeal disease
ResearchA Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution
ResearchEfficacy of bone-modifying agents in preventing vertebral complications of multiple myeloma: a systematic review and meta-analysis
ResearchThe Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
ResearchTranscriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study
ResearchRadiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)
ResearchUpdates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference
ResearchRandomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)
ResearchA randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)